TRIL
Trillium Therapeutics Inc.
TRIL
TRIL
Delisted
TRIL was delisted on the 16th of November, 2021.
26 hedge funds and large institutions have $23.2M invested in Trillium Therapeutics Inc. in 2017 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
Holders
26
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$4.62M | |
| 2 | +$4.42M | |
| 3 | +$2.64M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$2.4M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$1.98M |
Top Sellers
| 1 | -$1.65M | |
| 2 | -$1.4M | |
| 3 | -$261K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$143K |
| 5 |
Millennium Management
New York
|
-$62K |